Ask Warren

Genolution

225220 · KOSDAQ · ₩225220 · 제놀루션

₩1,717▲ ₩6 (0.35%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩3.1B₩2.5B₩2.4B₩2.1B₩2.9B₩2.1B₩2.1B₩1.7B
Cost of sales₩2B₩1.6B₩1.9B₩1.3B₩1.2B₩1.4B₩1.1B₩1.1B
Gross profit₩1.1B₩915M₩459M₩747M₩1.7B₩663M₩1B₩568M
Operating income−₩1.6B−₩1.4B−₩2B−₩2.4B−₩1.7B−₩2.5B−₩2.1B−₩2.5B
Net income₩503M₩440M−₩5.3B−₩1.3B−₩3.7B−₩2.3B−₩1.6B−₩3.3B
Net income to shareholders₩775M₩597M−₩5.1B−₩918M−₩3.5B−₩2.1B−₩1.5B−₩3.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩95B₩94B₩94B₩100B₩101B₩104B₩106B₩110B
Current assets₩33B₩33B₩33B₩35B₩36B₩38B₩37B₩39B
Cash and equivalents₩19B₩18B₩19B₩26B₩26B₩30B₩32B₩5.4B
Total liabilities₩26B₩26B₩26B₩26B₩26B₩26B₩26B₩27B
Current liabilities₩25B₩26B₩26B₩6.4B₩6.1B₩5.8B₩5.8B₩12B
Borrowings₩4.5B₩4.5B₩24B₩24B₩24B₩24B₩24B₩24B
Total equity₩69B₩68B₩68B₩73B₩75B₩78B₩80B₩83B
Shareholders' equity₩70B₩69B₩68B₩74B₩75B₩78B₩80B₩82B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩671M−₩693M−₩716M−₩927M−₩2.7B−₩2.6B−₩937M−₩442M
Capital spending₩102M₩114M₩7.7M₩50M₩199M₩37M₩916M₩2.9B
Free cash flow−₩773M−₩808M−₩724M−₩977M−₩2.9B−₩2.7B−₩1.9B−₩3.3B

Consolidated where available. Amounts in won.

Also known as: Genolution / 제놀루션 / 225220 / KRX:225220

Source: KRX statistical information